Published Scientific Articles
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Concarlo in the News
Webinars & Talks
Beyond Biotech podcast 24: Concarlo Therapeutics
LabOps: Changing Outcomes for Drug-Resistant Patients with Stacy Blain, Founder, and CSO at Concarlo Therapeutics
Opportunity to Join the Fight Against Metastatic Breast Cancer
Concarlo is on a Mission to Rid the World of Metastatic Breast Cancer
Awards
“The reward for work well done is the opportunity to do more”
—Jonas Salk
RESI’s Innovator’s Pitch Challenge Winner
Princeton University Women’s Showcase
The 50 Most admired companies: CIO Bio
Top 100 entreprenuers: Alumni List
Top Biotech Startup 2022
Awarded by: Life Sciences Review
